Drug profile · INN
teriparatide
SONDELBAY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
teriparatide (SONDELBAY) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN teriparatide
Brand SONDELBAY
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code H05AA02
Originator Amphastar France Pharmaceuticals
Frequently asked questions
What is teriparatide?
teriparatide (SONDELBAY) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for teriparatide?
SONDELBAY is a marketed brand name for teriparatide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teriparatide?
teriparatide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.